Quantifying the Survival Benefit for Allogeneic Stem Cell Transplantation in Relapsed Acute Myeloid Leukemia

Allogeneic hematopoietic stem cell transplantation (HSCT) is the recommended therapy for patients with relapsed AML despite little evidence showing a survival benefit for patients who undergo HSCT vs. chemotherapy alone. Because a prospective randomized trial addressing this issue is unlikely to be...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Armistead, Paul M., de Lima, Marcos, Pierce, Sherry, Qiao, Wei, Wang, Xuemei, Thall, Peter F., Giralt, Sergio, Ravandi, Farhad, Kantarjian, Hagop, Champlin, Richard, Estey, Elihu
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4067765/
https://ncbi.nlm.nih.gov/pubmed/19822303
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2009.07.008
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados